Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. SHEEPWOLF'S $1,000,000.00 JOURNEY Message Board

$IGEX: NEWS-- IGEX WELCOMES MARTINA LEON AS NEW C

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 107639
(Total Views: 448)
Posted On: 08/20/2019 9:16:20 AM
Avatar
Posted By: SHEEPWOLF
$IGEX: NEWS--
IGEX WELCOMES MARTINA LEON AS NEW CEO


Orlando, FL -- August 20, 2019 -- InvestorsHub NewsWire -- On May 6th 2019, HuLogix, Inc a Florida company, became a wholly owned subsidiary of Indo Global Exchange(s) PTE LTD

On August 16th Martina Leon was appointed CEO of IGEX. Now is the right time for a leadership change and Martina is the right person to guide IGEX/HuLogix through the coming era.

Martina has 27 years in the medical management field with 15 years in clinical trials. Martina has taken previous business from $450k revenue to over $1.3mm in less than a year. With her clinical trial experience, she has written protocols for current and incoming companion animal trials.

Ms .Leon has worked closely with James Hughes, DVM for over 8 years, and in such time they have developed several companion animal drugs, as well as companion animal procedures that are initiated and/or preparing for patent stage.

Dr. Jim was quoted, "I'm extremely excited for Hulogix/IGEX, Ms. Leon is an amazing CEO and is eager to open up HuLogix/IGEX to new and innovative avenues for research and development."

Ms. Leon quoted, "This is a great opportunity for everyone. HuLogix is a biopharmaceutical company for companion animal medicine and we growing by the day. I am eager, enthusiastic, and elated to be working with such a great team to improve the companion animal field. I'm looking forward to everyone taking this journey of growth with us."



We thank Mr. Black for all his efforts as previous CEO of IGEX.

For updates follow us on our website www.HuLogix.com



The official twitter https://twitter.com/HuLogix

Martina Leon, CEO IGEX

HuLogix/IGEX



(1)
(0)




Sojourner here following God, obeying God, and cleaving to Him. The journey is onward.





Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us